Matthew James

Matthew James

Auto-generated profile, based on publicly available information

Matthew James

Wear Referrals Veterinary Specialist & Emergency Hospital (part of Linnaeus Veterinary Limited, which is part of Mars Veterinary Health), Bradbury, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in Movement Disorders
Verified
Journal Article
Open access
MCMatthias Christen
Matthias Christen
RGRodrigo Gutierrez-Quintana
Rodrigo Gutierrez-Quintana
MJMatthew James
Matthew James
KFKiterie M.E. Faller
Kiterie M.E. Faller
MLMark Lowrie
Mark Lowrie
Tosso LeebTosso Leeb
Tosso Leeb
Background: Some paroxysmal movement disorders remain without an identified genetic cause.Objectives: The aim was to identify the causal genetic variant for a paroxysmal dystonia–ataxia syndrome in Weimaraner dogs.Methods: Clinical and diagnostic investigations were performed. Whole genome sequencing of one affected dog was used to identify private homozygous variants against 921 control genomes.Results: Four Weimaraners were presented for episodes of abnormal gait. Results of examinations and diagnostic investigations were unremarkable. Whole genome sequencing revealed a private frameshift variant in the TNR (tenascin‐R) gene in an affected dog, XM_038542431.1:c.831dupC, which is predicted to truncate more than 75% of the open read frame. Genotypes in a cohort of 4 affected and 70 unaffected Weimaraners showed perfect association with the disease phenotype.Conclusions: We report the association of a TNR variant with a paroxysmal dystonia–ataxia syndrome in Weimaraners. It might be relevant to include sequencing of this gene in diagnosing humans with unexplained paroxysmal movement disorders. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

24 August 2022 in Journal of Small Animal Practice
Verified
Journal Article
Closed access
MJM. James
M. James
MLM. Lowrie
M. Lowrie
DSD. Singleton
D. Singleton
LGL. Garosi
L. Garosi
KMK. McConnell
K. McConnell

1 January 2025 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
MJMatthew James
Matthew James
MLMark Lowrie
Mark Lowrie
Clare RusbridgeClare Rusbridge
Clare Rusbridge
Background: Myoclonus has been described in aging Cavalier King Charles Spaniels (CKCS), but the natural course of the disease and response to treatment have not been described. Objectives: Report the clinical features and course of myoclonus in CKCS. Animals: Twenty-seven caregivers provided questionnaire responses at a median of 24 months after the onset of myoclonus in their CKCS. Fifteen caregivers completed a second follow-up questionnaire at a median of 17 months after submission of the first questionnaire. Methods: The caregivers of affected CKCS were invited to provide video footage for review. Owners of CKCS with videos demonstrating myoclonus then completed the online questionnaire for further evaluation. A second shortened questionnaire was sent to participants at least 6 months after completion of the first. Results: Most CKCS displayed spontaneous myoclonus affecting predominantly the head (25/27). Overall, the majority had episodes that increased in frequency (20/27) and severity (17/27). Eighteen dogs had developed changes in behavior since the onset of myoclonus. These dogs were typically older and had experienced myoclonic episodes for longer than dogs without behavioral changes. Generalized epileptic seizures were reported in 4/27 dogs. Ten dogs received medical treatment. Eight were prescribed levetiracetam; all had an initial decrease in episode frequency, but a subsequent increase in both frequency and severity of episodes was common. Conclusions and Clinical Importance: Myoclonus in CKCS tends to progress in frequency and severity regardless of treatment. Progressive behavioral changes suggestive of cognitive decline are common. These findings support the possibility of an underlying neurodegenerative process.


3 July 2026 in Journal of Feline Medicine and Surgery Open Reports
Verified
Journal Article
Open access
Clare RusbridgeClare Rusbridge
Clare Rusbridge
FTFreya Townsend
Freya Townsend
APAnne-Lorraine Peschard
Anne-Lorraine Peschard
BLBrian Love
Brian Love
MJMatthew James
Matthew James
FSFabio Stabile
Fabio Stabile
Case summary: A 6-year-8-month-old neutered male Ragdoll cat was investigated for peracute right-sided neurological deficits consistent with a C1–C5 myelopathy. Initial MRI identified an intramedullary lesion at C2, most consistent with ischaemic myelopathy. The cat improved with physiotherapy; however, on day 21, it developed recurrent episodes of abnormal limb posturing and involuntary movements. Episodes comprised segmental dystonia with a spreading pattern, preserved consciousness, and no consistent autonomic signs, supporting a paroxysmal dyskinesia (PD)-like movement disorder rather than epileptic seizures. Brain MRI performed on day 24 identified a focal wedge-shaped lesion in the rostroventral right cerebellar hemisphere within the territory of the rostral cerebellar artery, consistent with a subacute infarct. Additional findings, including renal infarction supported multifocal thromboembolic disease. The temporal association between cerebellar infarction and onset of paroxysmal episodes supported a diagnosis of secondary PD. Clopidogrel was initiated. Further episodes occurred 46 and 87–90 days later; the latter cluster coincided with the presence of two visiting dogs. Two episodes were associated with owner-reported nystagmus alongside PD signs consistent with those observed previously. Relevance and novel information: This report describes a novel PD-like movement disorder associated with cerebellar infarction in a cat. Unlike most reported feline PD cases, which are idiopathic or metabolic (hyperthyroidism), it supports a structural cerebrovascular aetiology involving cerebellar motor networks. Although causality cannot be definitively established, the findings support emerging concepts that paroxysmal dyskinesia may arise from dysfunction within distributed motor networks, including cerebellar–thalamo–cortical pathways, rather than being exclusively attributable to basal nuclei circuitry.